Company
United StatesMolecular PharmaGroup, New Providence, NJ – FDA Inspections
Inspection records and compliance data for Molecular PharmaGroup in New Providence, New Jersey. 2 FDA inspections on record, 2 Form 483s, last inspected August 11, 2025.
Company Profile
This profile covers Molecular PharmaGroup based in New Providence, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 2
- NAI
- 0
- Form 483s
- 2
- Warning letters
- 0
First inspected December 11, 2023. Last inspected August 11, 2025.
Most cited issue areas
- All inclusive product report, not submitted1 inspection
- Drug product labels, fails to include1 inspection
- Equipment to control conditions1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 11, 2025 | VAI | Human Drugs · Drug Quality Assurance | 1278107 |
| December 11, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1224590 |
FDA documents
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Molecular PharmaGroup
FEI Number
3014413265
Address
755 Central Ave Unit 2 Unit 4, New Providence, New Jersey 07974, United States
Country
United States
ID: 284f8e5d-cf64-49a4-80cb-59cd24428b20